arrow_back Back to feed
W

WuXi Biologics

News

W
WuXi Biologics Aug 07

WuXi Biologics, a biopharmaceutical company, is considering selling its U.S. facilities, as reported by BioSpace. The decision comes amid concerns over the BIOSECURE Act, which could restrict operations of Chinese companies in the U.S.

open_in_newwww.biospace.com

Reviews

No reviews yet.

Leave your review